fda cleared immunoassay semaglutide detection GLP-1 Assay Services Compounded Semaglutide: Safety & Regulation

27,33 Although a higher maintenance dosage of semaglutide (2.4 mg/wk) was used in this trial, the adverse event profile and tolerability were consistent with data from a phase 2 study in people with obesity 14 and semaglutide trials in patients with type 2 diabetes using lower maintenance dosages (up to 1.0 mg/wk), 34 as well as with that reported for other GLP-1 receptor agonists, 35 with no new concerns

& Wilson, A

It's taking the first step

Sustainability is a core part of every Vesta protocol

When Wegovy reduces physical hunger, the psychological desire for sugaroften linked to stress, boredom, or reward-seeking behaviourmay become more noticeable

The side effect profiles of semaglutide versus tirzepatide differ enough that switching can help some people